Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Freenome Holdings Inc.
Age
30–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age ≥30 years within 30 days of enrollment
Able and willing to provide blood samples per protocol
Able to comprehend and willing to sign and date the informed consent and HIPAA
Authorization documents
Able and willing to allow existing health data to be utilized for study purposes
You may not be if
Any history of solid organ or bone marrow transplantation
Any physical trauma or surgery requiring inpatient overnight hospitalization in the 30 days preceding enrollment
Received a blood transfusion in the 30 days preceding enrollment
A medical condition that, in the opinion of the Investigator, should preclude enrollment in the study
Known to be pregnant
Any therapy for cancer, including but not limited to surgery, chemotherapy, biologic therapy, immunotherapy, and/or radiation therapy in the 5 years preceding enrollment
Participated or currently participating in a clinical research study in which an experimental medication has been administered during the 30 days preceding enrollment
Participated or currently participating in another Freenome-sponsored clinical study
For non-cancer groups: Any previous cancer diagnosis in the 5 years preceding enrollment; OR recurrence of the same primary cancer within any timeframe; OR concurrent diagnosis of multiple primary cancers within any timeframe
For the cancer groups: Any previous cancer diagnosis in the 5 years preceding enrollment, apart from the current cancer diagnosis; OR recurrence of the same primary cancer within any timeframe; OR concurrent diagnosis of multiple primary cancers within any timeframe
Clareo Health | The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
